Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

UVEDIN 25.000 UI/2,5 ML SOLUCION ORAL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/UVEDIN 25.000 UI/2,5 ML SOLUCION ORAL

Approved

STANDARD

UVEDIN 25.000 UI/2,5 ML SOLUCION ORAL

Laboratorios Lorien S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Dec 22, 2022
Approval ID: be8123ce15f8bc99
Company: Laboratorios Lorien S.L.
Type: Standard

Approval Details

Approval Id: be8123ce15f8bc99
Drug Cima Aemps Name: UVEDIN 25.000 UI/2,5 ML SOLUCION ORAL
Register Number: 88427
Holder Company Name: Laboratorios Lorien S.L.
Marketing Company Name: Laboratorios Lorien S.L.
Authorization Date: 2022-12-22
Dosage Form: SOLUCIÓN ORAL
Dose: 25.000 UI/2.5 ml
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Laboratorios Lorien S.L.

Active Ingredients

COLECALCIFEROL

0,62 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 22, 2022

Approval ID

be8123ce15f8bc99

Type

Standard

Back to CIMA-AEMPS Approvals